1a/1b Study of OPT101 First in Human Study Assessing Safety and Tolerability of 15-mer Peptide.
Clinical trial NCT04589403 · COMPLETED
Trial details
- NCT number
- NCT04589403
- Sponsor
- Op-T LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-02-18
- Primary completion
- 2021-09-27
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.